미래의 항우울제
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 사공정규 | - |
dc.contributor.author | 이민수 | - |
dc.date.accessioned | 2021-09-07T18:01:44Z | - |
dc.date.available | 2021-09-07T18:01:44Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 1225-9454 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/113837 | - |
dc.description.abstract | Recent advances in research on depression have confirmed that it is common, chronic, recurrent and disabling men-tal disorder. The treatment of depression has gained growing importance because of its major impact on the patient’s wellbeing, personal and social achievements. Recently, as an increasing number of antidepressants of various types continue to be developed for the treatment of depression, psychopharmacotherpy is the major approach to depression in clinical setting. Unfortunately, there are clear limitations to the currently approved pharmacotherapies of depression, including the fact that they are all essentially monoamine based, have modest efficacy and a relatively slow onset of efficacy, and suffer from significant tolerability issues. Recently, several promising hypotheses of depression and antidepressant action have been formulated. These hypotheses are based on dysregulation of hypothalamic-pituitary-adrenal(HPA) axis, neurotrophic mechanisms, glutamate, neurokinin, phosphodiesterase, cytokines. This article reviews these most promising novel mechanisms that are not represented in compounds currently approved for de-pression in either the United States or Europe and that may represent the future of the psychopharmacologic treatment of depression. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | 대한생물치료정신의학회 | - |
dc.title | 미래의 항우울제 | - |
dc.title.alternative | Future Antidepressants | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 이민수 | - |
dc.identifier.bibliographicCitation | 생물치료정신의학, v.17, no.2, pp.153 - 163 | - |
dc.relation.isPartOf | 생물치료정신의학 | - |
dc.citation.title | 생물치료정신의학 | - |
dc.citation.volume | 17 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 153 | - |
dc.citation.endPage | 163 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001615119 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | 항우울제·우울증·시상하부-뇌하수체-부신피질축·신경영양성인자·글루탄산염·뉴로키닌· 포스포디에스테라제·사이토카인 | - |
dc.subject.keywordAuthor | Antidepressant · Depression · HPA axis · Neurotrophic factor · Glutamate · Neurokinin ·Phosphodiesterase · Cytokines | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.